Literature DB >> 1680646

Changes in pharmacokinetics of cisplatin after hepatic resection in rats.

K S Hall1, B Lien, L Endresen, A Bergan, H E Rugstad.   

Abstract

Adjuvant chemotherapy concomitant with hepatic resection has been considered as treatment of patients with hepatocarcinoma. To examine the influence of a partial hepatectomy on the platinum pharmacokinetics, rats were given a single dose of cisplatin (2 mg/kg) prior to 2/3 hepatic resection or sham operation. The partially hepatectomized rats showed a 44% increase in the AUC between 2-48 hr compared with the sham-operated controls. The terminal plasma half-life from 12-48 hr was 21.1 hr for the partially hepatectomized rats and 14.7 hr for the sham-operated animals. Total platinum concentration in liver tissue was 1.3 times that of plasma 20 min after injection. Although cisplatin is considered to be eliminated mainly via renal excretion, our finding may suggest a role for the liver in the elimination of platinum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680646

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  3 in total

1.  Systemic Delivery and Biodistribution of Cisplatin in Vivo.

Authors:  Yu-Hsuan Chu; Martha Sibrian-Vazquez; Jorge O Escobedo; Amanda R Phillips; D Thomas Dickey; Qi Wang; Martina Ralle; Peter S Steyger; Robert M Strongin
Journal:  Mol Pharm       Date:  2016-06-24       Impact factor: 4.939

2.  Influence of partial hepatectomy in rats on the activity of hepatic microsomal enzymatic systems.

Authors:  A M Maza; A R Gascon; M B Calvo; R M Hernandez; M A Monte; J J Marin; A Dominguez-Gil; J L Pedraz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.569

3.  Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004).

Authors:  Masanori Toyoda; Tetsuo Ajiki; Yutaka Fujiwara; Hiroaki Nagano; Shogo Kobayashi; Daisuke Sakai; Etsuro Hatano; Masashi Kanai; Shoji Nakamori; Atsushi Miyamoto; Akihito Tsuji; Satoshi Kaihara; Hisashi Ikoma; Shigekazu Takemura; Hideyoshi Toyokawa; Hiroaki Terajima; Satoshi Morita; Tatsuya Ioka
Journal:  Cancer Chemother Pharmacol       Date:  2014-03-11       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.